Study on how nerve damage affects semaglutide stomach emptying
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial looks at how having neuropathy (nerve damage) might increase the risk of food staying too long in the stomach when taking semaglutide. It could help find out who needs extra monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diabetes
- You've been taking semaglutide for at least 4 weeks and haven't stopped
- You are 18 or older
- You are in good physical health (ASA I-II)
- You can fast 8 hours and avoid water 4 hours before a stomach scope
- You had tests for nerve damage in your body and feet within 2 weeks before the scope
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if stopping semaglutide (a diabetes/weight-loss drug) for one week before a sedated endoscopy helps reduce leftover food in the stomach and improves how well doctors can see the stomach lining. It may help patients who need a clear view during the procedure.
This study uses an ultrasound to look at how full your stomach is after taking GLP-1 medications for diabetes or weight loss. It will help doctors understand if current fasting guidelines are safe before surgery or a colonoscopy.
This study uses a non-invasive test (body surface gastric mapping) to look at stomach activity in people taking semaglutide. It aims to understand how the medicine affects digestion.
This study looks at how genetics may affect your body’s early response to oral semaglutide, a weight-related diabetes medicine. You may be considered if you are overweight (or overweight with prediabetes) and can safely take part in the research.
This study looks at how fast the stomach empties in healthy volunteers and people taking semaglutide (a GLP-1 agonist drug for diabetes or weight loss). It may help understand how this drug affects digestion.
This study compares different diets to see how they affect “arterial stiffness” (how hard the blood vessels are) in people with obesity who are starting semaglutide for weight management. It may help find a diet approach that improves heart and blood-vessel health while you use semaglutide.
Hear when a new Gastric Retention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.